Emily Carter
Adult Medicine · Bridgeport, CTNPI 1477068773
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,723, more than ten times the $19 reported in 2020.
Across 182 payments — averaging $24.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$789
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$486
- Viiv Healthcare Company$457
- Otsuka America Pharmaceutical, Inc.$437
- AstraZeneca$414
- Novo Nordisk$220
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,07892%
- Education$3398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $789 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $486 |
| Viiv Healthcare Company | 18 | $457 |
| Otsuka America Pharmaceutical, Inc. | 19 | $437 |
| AstraZeneca | 15 | $414 |
| Novo Nordisk | 11 | $220 |
| GSK | 11 | $216 |
| Pfizer | 9 | $195 |
| Neurocrine Biosciences, Inc. | 6 | $188 |
| Janssen Products, LP | 2 | $149 |
| Boehringer Ingelheim | 7 | $132 |
| E.r. Squibb & Sons, L.L.C. | 1 | $106 |
| Teva Pharmaceuticals USA, Inc. | 5 | $105 |
| Gilead | 5 | $93 |
| Johnson & Johnson(2 entities) | 4 | $93 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Exact Sciences | 2 | $50 |
| Alkermes, Inc. | 2 | $50 |
| Merck | 2 | $47 |
| Indivior Inc. | 2 | $40 |
| Theratechnologies Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult medicine providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $46,801 |
| JardianceEmpagliflozin | 29 | $25,712 |
| LinzessLinaclotide | 37 | $23,501 |
| JanuviaSitagliptin Phosphate | 23 | $22,514 |
| TradjentaLinagliptin | 34 | $21,186 |
| JanumetSitagliptin Phos/Metformin Hcl | 23 | $20,231 |
| EliquisApixaban | 26 | $19,311 |
| FarxigaDapagliflozin Propanediol | 17 | $11,742 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 14 | $2,774 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $2,017 |
| Doxepin Hcl | 12 | $1,940 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,135 |
| Amlodipine Besylate | 204 | $841 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 13 | $761 |
| Celecoxib | 19 | $710 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $132 | $46,89863 claims |
| Novo NordiskOzempic | $220 | $46,80138 claims |
| MerckJanuvia, Janumet | $47 | $42,74546 claims |
| AbbVieLinzess | $789 | $23,50137 claims |
| PfizerEliquis | $195 | $19,31126 claims |
| AstraZenecaFarxiga | $414 | $11,74217 claims |
| GSKShingrix | $216 | $2,77414 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $19 | $33311 claims |
| Lilly USA, LLCInsulin Lispro | $18 | $28511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult medicine providers in Connecticuton file to place this against a meaningful peer group, so we don't.
Other adult medicine in Bridgeport
- Maria MikolaenkoBridgeport$149
- Yogesh KatechiaNorwich$9K
- Deepthi NaikFairfield$2K
- Kevin CollinsHartford$1K
- Gabriella FormanStamford$375
- Kenneth MancherSeymour$335
- Matthew ScottGreenwich$250
- Caitlin BalintNewtown$52
- Alicja HarbutNew Britain$41
- Shruti KumarNorth Haven$26
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.